4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001732369-26-000010
CHIEF EXECUTIVE OFFICER acquired 55,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Seehra Jasbir · CHIEF EXECUTIVE OFFICER
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-02 | Exercise or conversion : show line 1 in the form | +55,000 | $0.30 | $16,500 | 440,708 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-04-02 | Exercise or conversion : show line 2 in the form Employee Stock Option (Right to Buy) | −55,000 | 197,444 | D |
Loading xslF345X06/form4-04062026_040401.xml…